COVID Vaccine

Fired vaccine experts warn that Health Secretary Robert F. Kennedy Jr.’s overhaul of the Centers for Disease Control and Prevention’s key vaccine advisory panel threatens public health and undermines decades of immunization progress. What Happened: Seventeen ousted members of the CDC...

U.S. Health Secretary Robert F. Kennedy Jr. has championed “medical freedom” while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy. What Happened: Kennedy...

The President Donald Trump administration’s request for Novavax Inc. (NASDAQ:NVAX) to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its...

Florida Governor Ron DeSantis' administration has reportedly issued updated guidance recommending that healthcare providers steer vulnerable patients away from mRNA-based COVID-19 vaccines. The Florida Health Department is raising concerns about the safety of the mRNA vaccines, pointing to...

In a peculiar case, a 62-year-old man from Germany has reportedly received 217 COVID-19 vaccine doses, defying medical advice. The man has not suffered any adverse effects. What Happened: The man, who chose to remain anonymous, received the vaccines privately over a period of 29 months, reported...

Gritstone bio Inc (NASDAQ:GRTS) shares are trading lower after the company announced an approximately 40% reduction of its workforce.  The move comes following the recently announced delay of the proposed CORAL Phase 2b study, which resulted in Gritstone not receiving the external...

For the first time since July 2020, Walgreens Boots Alliance Inc (NASDAQ: WBA) missed earnings expectations. Besides its disappointing fiscal third-quarter results, the retail pharmacy chain also slashed its full year earnings guidance in the face of lower consumer spending and a drop in demand for...

Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday. What Happened: The Food and Drug Administration (FDA) will likely authorize the booster shots of Pfizer, Inc. (NYSE: PFE)/BioNTech SE (NASDAQ...

This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here. The news: A panel advising the Food and Drug Administration recommended approving COVID-19 booster shots only for people over age 65 and people who have a high risk of developing severe COVID-19...

Air Canada (OTC: ACDVF) introduced a new health and safety policy, making it mandatory for all airline employees to be fully vaccinated against COVID-19 and report their vaccination status on October 30, 2021. Recently, the Government of Canada directed employees in the federally...

Investors may be scratching their heads at the resiliency shown by the major U.S. stock indices as of late. Despite the Delta variant unleashing renewed fears of economic shutdowns globally and other factors that should be dampening markets – supply chain issues, labor and semiconductor...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and...

Pfizer (NYSE:PFE) shares experienced unusual options activity on Friday. The stock price moved up to $49.6 following the option alert. Sentiment: BEARISH Option Type: SWEEP Trade Type: CALL Expiration Date: 2021-12-17 Strike Price: $50.00 Volume: 2914 Open Interest: 13281 Three Signs Of Unusual...

Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue. Q2...